Precore hepatitis B virus mutants have been detected mainly in HBeAg-negative patients with active liver disease. We previously reported two novel mutations: M, (C-to-T change at nucleotide 1856 [proser at codon 151) and M, (G-to-A change at nucleotide 1898 [gly-ser at codon 291) in addition to two
Detection of hepatitis B virus precore stop codon mutants by selective amplification method: Frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers
✍ Scribed by SUSUMU NAKAHORI; OSAMU YOKOSUKA; TOSHIKI EHATA; WANG-LONG CHUANG; FUMIO IMAZEKI; YOSHIMI ITO; MASAO OHTO
- Book ID
- 118704496
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 810 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ؍ 60
The objective of this study was to evaluate the role of hepatitis B virus (HBV) precore mutations in patients with anti-me-positive chronic hepatitis B with or without previous known HBe antigen (HBeAg) viremic phase, and to assess the potential implication of precore mutants in HBeAg-negative react